Digital Cognitive Biomarkers
Embic Corporation’s digital cognitive biomarkers (DCBs) quantify underlying cognitive processes of encoding and retrieval that cannot be directly observed and have been previously inaccessible. This scientific innovation has been achieved through research & development efforts that leverage the combination of proprietary cognitive modeling approaches and Embic’s massive normative dataset. The modeling approaches include hierarchical Bayesian and multinomial tree processing methods; Embic’s dataset contains item-level responses to well-validated wordlist learning and recognition tasks from nearly 2 million healthy subjects across the adult human life span.
Embic’s DCBs facilitate a non-invasive and pragmatic approach to characterizing cognitive function at a granular level, which enables identification and quantification of subtle but meaningful cognitive changes. This capability unlocks a profound opportunity for accelerating and optimizing results in clinical trials, especially in the areas of cognitive aging and neurodegenerative diseases.
Additional resources are available including:
A detailed description of the development, validation, and utility of Embic’s DCBs
A complete list of currently available DCBs